<DOC>
	<DOCNO>NCT01245608</DOCNO>
	<brief_summary>The primary purpose study determine effect fix dose combination valsartan , hydrochlorothiazide , atorvastatin aspirin ( PolyPill ) prevention cardiovascular event adult older 50 . Various liver-related variable also record allow study effect PolyPill liver effect liver diseases nonalcoholic steatohepatitis cardiovascular event protective effect PolyPill .</brief_summary>
	<brief_title>Prevention Cardiovascular Disease Using Single PolyPill Urban Population - Focus Liver-Related Variables .</brief_title>
	<detailed_description>2400 subject randomly select participant Golestan Cohort Study ( GCS ) live Gonbad 50 year old . These subject randomize either receive PolyPill treatment . Those agree study undergo additional measurement ( addition baseline measurement perform GCS ) include liver-related test liver enzyme level , abdominal ultrasonography liver stiffness measurement . Some additional test color doppler ultrasonography carotid vessel also perform . Subjects PolyPill arm contraindication component pill receive single daily dose PolyPill 5 year .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Being enrol Golestan Cohort Study Debilitating disease cause inability comply Contraindications component PolyPill Not consent study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Atorvastatin</keyword>
	<keyword>Aspirin</keyword>
	<keyword>nonalcoholic steatohepatitis</keyword>
	<keyword>nonalcoholic fatty liver disease</keyword>
	<keyword>antihypertensive agent</keyword>
</DOC>